Actinic keratosis (AK) affects millions worldwide, appearing as rough, scaly patches on sun-exposed skin—typically the face, hands, and shoulders. Caused by cumulative sun damage, these lesions are remarkably common: 40–50% of Caucasian Australians develop AK by age 40, while roughly 10% of European populations are affected .
Beyond cosmetic concerns, AK carries serious implications. These lesions represent premalignant changes in skin cells and can progress to squamous cell carcinoma if left untreated. Current standard treatments include surgical removal or topical immunomodulatory agents like 5-fluorouracil and imiquimod. However, these conventional approaches often cause significant side effects, including burning, irritation, contact dermatitis, and even flu-like symptoms—leading many patients to abandon treatment prematurely.
Enter medical grade Kanuka honey. This New Zealand native honey has demonstrated potent immunomodulatory and antimitotic properties in laboratory studies, suggesting it may help regulate abnormal cell growth while reducing inflammation. Unlike conventional treatments, honey offers a gentle, natural alternative with an excellent safety profile.
A compelling case published in Case Reports in Dermatology illustrates this potential. A 66-year-old man presented with a 21×20mm crusted, scaly lesion on his hand that had persisted for years. After applying Honevo® medical grade Kanuka honey daily for three months, the lesion completely resolved. Remarkably, at nine-month follow-up, there was no sign of recurrence, and the patient remained clear at two years.
While larger clinical trials are needed to confirm these findings, this case suggests Kanuka honey could offer an effective, well-tolerated treatment option for AK—particularly for patients seeking alternatives to harsh conventional therapies.
For those struggling with sun-damaged skin, this natural remedy may be worth discussing with a dermatologist.
We do not offer a specific product for AK, but our Rosacea product is exactly the same honey/formulation/specifications as that used by the patient in the case report.
0 comments